Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

BLFS – BioLife Solutions, Inc.

BioLife Solutions, Inc.
BLFS
$21.54
Name : BioLife Solutions, Inc.
Sector : Healthcare
Industry: Medical Instruments & Supplies
Mark. Cap: $1,024,468,288.00
EPSttm : -0.19
finviz dynamic chart for BLFS
BioLife Solutions, Inc.
$21.54
0.23%
$0.05

Float Short %

9.55

Margin Of Safety %

-16

Put/Call OI Ratio

0.76

EPS Next Q Diff

0.01

EPS Last/This Y

0.46

EPS This/Next Y

0.14

Price

21.49

Target Price

31.22

Analyst Recom

1

Performance Q

-17.88

Relative Volume

1.59

Beta

1.81

Ticker: BLFS




19 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-06-02BLFS20.651.45100.00255
2025-06-03BLFS21.371.45102.33255
2025-06-04BLFS221.45102.33255
2025-06-05BLFS21.491.45102.33255
2025-06-06BLFS23.754.400.00562
2025-06-09BLFS23.834.450.00561
2025-06-10BLFS23.954.450.00561
2025-06-11BLFS23.714.450.00561
2025-06-12BLFS23.264.450.00561
2025-06-13BLFS21.994.32999.99564
2025-06-16BLFS22.284.36999.99568
2025-06-17BLFS21.754.350.00567
2025-06-18BLFS21.534.310.00568
2025-06-20BLFS21.194.270.00569
2025-06-23BLFS21.360.780.33158
2025-06-24BLFS21.780.780.27158
2025-06-25BLFS21.290.780.00164
2025-06-26BLFS21.440.770.00166
2025-06-27BLFS21.510.760.67167
DateSymbolLastP/C OIP/C VolTotal OI
19 items Current Page1 of 1




19 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-06-02BLFS20.6585.2- 0.02
2025-06-03BLFS21.3885.2- 0.02
2025-06-04BLFS22.0185.2- 0.02
2025-06-05BLFS21.5085.2- 0.02
2025-06-06BLFS23.7385.2- 0.02
2025-06-09BLFS23.8485.2- 0.02
2025-06-10BLFS23.9485.2- 0.02
2025-06-11BLFS23.7685.2- 0.02
2025-06-12BLFS23.3085.2- 0.02
2025-06-13BLFS22.0385.2- 0.02
2025-06-16BLFS22.2985.2- 0.02
2025-06-17BLFS21.7385.2- 0.02
2025-06-18BLFS21.5285.2- 0.02
2025-06-20BLFS21.2285.2- 0.02
2025-06-23BLFS21.3685.2- 0.02
2025-06-24BLFS21.7985.2- 0.02
2025-06-25BLFS21.3185.2- 0.02
2025-06-26BLFS21.4785.2- 0.02
2025-06-27BLFS21.4985.2- 0.02
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
19 items Current Page1 of 1




18 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-06-02BLFS-7.982.539.10
2025-06-03BLFS-7.982.539.10
2025-06-04BLFS-7.982.539.10
2025-06-05BLFS-7.822.539.11
2025-06-06BLFS-7.822.539.11
2025-06-09BLFS-7.822.569.11
2025-06-10BLFS-7.942.569.11
2025-06-11BLFS-7.942.5610.26
2025-06-12BLFS-7.942.5610.26
2025-06-13BLFS-37.672.5610.26
2025-06-16BLFS-37.672.5010.26
2025-06-18BLFS-37.672.5010.26
2025-06-20BLFS-37.262.5010.26
2025-06-23BLFS-37.26-0.3010.26
2025-06-24BLFS-37.26-0.3010.26
2025-06-25BLFS-37.26-0.3010.26
2025-06-26BLFS-37.26-0.309.55
2025-06-27BLFS-37.26-0.309.55
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
18 items Current Page1 of 1

Last Quarter Act. EPS

-0.01

Avg. EPS Est. Current Quarter

-0.01

Avg. EPS Est. Next Quarter

-0.01

Insider Transactions

-37.26

Institutional Transactions

-0.3

Beta

1.81

Average Sales Estimate Current Quarter

23

Average Sales Estimate Next Quarter

24

Fair Value

18.05

Quality Score

46

Growth Score

47

Sentiment Score

41

Actual DrawDown %

64.6

Max Drawdown 5-Year %

-85.1

Target Price

31.22

P/E

Forward P/E

247.47

PEG

P/S

9.68

P/B

2.9

P/Free Cash Flow

88.19

EPS

-0.04

Average EPS Est. Cur. Y​

0.02

EPS Next Y. (Est.)

0.16

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-1.44

Relative Volume

1.59

Return on Equity vs Sector %

-26.9

Return on Equity vs Industry %

-11.6

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

BioLife Solutions, Inc.
Sector: Healthcare
Industry: Medical Instruments & Supplies
Employees: 159
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line include automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.
stock quote shares BLFS – BioLife Solutions, Inc. Stock Price stock today
news today BLFS – BioLife Solutions, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch BLFS – BioLife Solutions, Inc. yahoo finance google finance
stock history BLFS – BioLife Solutions, Inc. invest stock market
stock prices BLFS premarket after hours
ticker BLFS fair value insiders trading